Analysts Slash Their PTs on Oracle as They Did Not Buy Its Growth Story

By Benzinga
March 14, 2022 Updated: March 14, 2022

Analysts slashed their price targets on Oracle Corp post Q3 results.

Piper Sandler analyst Brent Bracelin downgraded to Underweight from Neutral with a PT of $70 (8.7 percent downside), down from $100.

Bracelin found it challenging to reach double-digit organic growth next year, sustaining a cloud shift considering more than 70 percent of revenue came from the traditional Oracle product categories.

BofA analyst Brad Sills lowered the PT to $90 from $105 (17.4 percent upside) and kept a Neutral.

Sills also did not buy the company’s cloud outlook and margin expansion story.

Wolfe Research analyst Alex Zukin lowered the PT to $83 from $105 (8.3 percent upside) peer multiple contractions and kept a Peer Perform.

Zukin noted “strong” fiscal Q3 results with accelerating constant-currency revenue coupled with double-digit sales growth and expanding margins for fiscal 2023.

By Anusuya Lahiri

© 2021 The Epoch Times. The Epoch Times does not provide investment advice. All rights reserved.